Published in Gene Therapy Weekly, July 3rd, 2003
These results, presented at the American Society of Gene Therapy (ASGT) annual meeting, achieve a milestone in the development of its procedures for potential treatment of sickle cell disease. Specifically, these data demonstrate successful alteration of a single base pair in the beta-globin gene from normal to sickle.
NaPro is now investigating the use of the same approach to correct mutant sickle cells to a normal state with the ultimate hope of providing effective...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.